Form 4: Adaptive Biotechnologies Director Peter Neupert Acquires Shares and Options

Director Peter Neupert acquired shares and options in Adaptive Biotechnologies on March 4, 2024.

Summary

• On March 4, 2024, Peter M Neupert, a director of Adaptive Biotechnologies Corp, acquired 31,328 shares of common stock at $0.
• Following the transaction, Neupert directly owns 154,296 shares.
• Neupert also acquired options to purchase 48,044 shares of common stock at an exercise price of $3.99, exercisable over one year from March 4, 2024.
• The options expire on March 4, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing insider transactions. The acquisition of shares and options by a director could be interpreted as a mildly positive signal, but it's not a major event.

Positives

• A director's acquisition of shares and options can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the options suggests a continued relationship between the director and the company for at least one year.

Industry Context

This filing is a routine disclosure related to insider transactions. It doesn't provide specific insights into Adaptive Biotechnologies' competitive position or broader industry trends.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates